Israel Biotech Fund I, L.P.
I.b.f. · adviser of record: I.B.F. Management LTD. · 2015 vintage
Israel Biotech Fund I, L.P. is a 2015 venture fund managed by I.b.f., with $100mm raised (Form D, amount sold). It reported $25mm in gross assets at year-end 2025, 0.25x its size, against a peak of $25mm in 2018.
- Latest value held
- $25mm year-end 2025
- Peak
- $25mm year-end 2018
- Fund size
- $100mm Form D, amount sold
- Held vs. size
- 0.25x peak 0.25x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $25mm | 0.25x | +0% over 2 yrs |
| 2023 | $25mm | 0.25x | +0% |
| 2022 | $25mm | 0.25x | +0% |
| 2021 | $25mm | 0.25x | +0% |
| 2020 | $25mm | 0.25x | +0% |
| 2019 | $25mm | 0.25x | +0% |
| 2018 | $25mm | 0.25x | – |
Other funds from I.b.f.
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-3791898329. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.